Financial statements Ipharm 2
Balance sheet data of IPHARM 2
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 829 436,31 | 824 350,69 | 864 960,63 | 974 249,06 | 728 287,30 | 1 046 828,33 |
A. Fixed assets | 90 141,77 | 90 344,26 | 74 401,30 | 58 458,34 | 59 269,56 | 62 684,64 |
B. Current assets | 739 294,54 | 734 006,43 | 790 559,33 | 915 790,72 | 669 017,74 | 984 143,69 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 829 436,31 | 824 350,69 | 864 960,63 | 974 249,06 | 728 287,30 | 1 046 828,33 |
A. Equity | -980 148,81 | -1 022 794,35 | -1 123 757,42 | -997 124,24 | -1 148 303,22 | -1 249 915,16 |
B. Liabilities and provisions for liabilities | 1 809 585,12 | 1 847 145,04 | 1 988 718,05 | 1 971 373,30 | 1 876 590,52 | 2 296 743,49 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.